Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Asia Pacific Herald.
Press releases published on March 27, 2025

LIXTE Biotechnology Provides Update On Progress with Proprietary Compound, LB-100, to Treat Ovarian and Colorectal Cancer
-Started Two New Clinical Trials, Collaborating with MD Anderson and The Netherlands Cancer Institute for Treatment of Ovarian and Colorectal Cancer- -Received Exclusive Patent License Agreement with the NIH on LB-100's Potential in Enhancing Cancer …

BGIN Blockchain Limited Introduces New Industry-leading ICERIVER Mining Machines, Enhancing Accessibility for Crypto Mining
Singapore, March 27, 2025 (GLOBE NEWSWIRE) -- BGIN Blockchain Limited (“BGIN”), a leading blockchain infrastructure provider specializing in high-performance mining machines and a range of comprehensive services, has launched its latest suite of ICERIVER …

CURRENC’s SEAMLESS AI Lab Unveils “AI Staff for Hire” Platform
SINGAPORE, March 27, 2025 (GLOBE NEWSWIRE) -- CURRENC Group Inc. (Nasdaq: CURR) (“CURRENC” or the “Company”), a fintech pioneer empowering financial institutions worldwide with artificial intelligence (AI) solutions, today announced the launch of “AI Staff …

CURRENC集团旗下SEAMLESS AI实验室重磅发布“AI助手”平台
新加坡, March 27, 2025 (GLOBE NEWSWIRE) -- CURRENC Group Inc. (纳斯达克代码:CURR)(以下简称“CURRENC”或“公司”),一家通过人工智能(以下简称“AI”)解决方案在全球范围赋能金融机构的金融科技先驱企业,今日重磅发布由公司旗下SEAMLESS AI实验室开发的“AI助手”平台,推出一系列针对具体业务场景定制的即用型AI代理人功能。随着AI自动化在全球范围重塑各行各业,凭借这一创新产品,CURRENC在蓬勃发展的劳动力AI …

CNC machine Market Size to Hit $ 122.4 Billion, Globally, by 2031 | Exclusive Report by The Insight Partners
US …

AIM ImmunoTech Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update
Continued execution across Ampligen® (rintatolimod) clinical development programs in areas with critical unmet needs, especially in the high-value pancreatic cancer space Expected milestones over the course of the next 18 months provide significant value- …

Rectitude Holdings Ltd Announces Fiscal 2025 First Half Financial Results
SINGAPORE, March 27, 2025 (GLOBE NEWSWIRE) -- Rectitude Holdings Ltd (the “Company” or “Rectitude”), a Singapore-based provider of safety equipment and related industrial-grade hardware products, today announced its unaudited financial results for the six …

匈牙利Helvetic牙科诊疗中心2024年再创佳绩,成为布达佩斯最佳牙科诊所
BUDAPEST, BUDAPEST, HUNGARY, March 27, 2025 /EINPresswire.com/ -- Helvetic 牙科诊疗中心被誉为匈牙利最佳牙科诊所,在2024年再次取得了卓越的成绩。2024年新增四个诊室的决定是一个及时且战略性的举措,使诊所能够迅速满足日益增长的海外牙科理疗需求,尤其是在快速发展的牙科旅游领域。 通过此次扩容,Helvetic …

Primech Holdings Limited Provides Financial Updates and Corporate Highlights For the Six Months Ended September 30, 2024
SINGAPORE, March 27, 2025 (GLOBE NEWSWIRE) -- Primech Holdings Limited (the “Company”) (Nasdaq: PMEC), an established technology-driven facilities services provider in the public and private sectors operating mainly in Singapore, provides a financial and …

New Data to Be Presented at Upcoming Congresses Showcase Cerevance's Advanced Clinical Program in Parkinson’s Disease and Deep Pipeline for CNS-based Disorders
Topline results from Phase 2 ASCEND trial of solengepras as a monotherapy treatment for early-stage Parkinson’s to be presented First presentation of data from Phase 1 trial of novel KCNK13 inhibitor for CNS diseases targeting neuroinflammation Additional …

Vaxart, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
SOUTH SAN FRANCISCO, Calif., March 27, 2025 (GLOBE NEWSWIRE) -- Vaxart, Inc. (Nasdaq: VXRT) (the “Company” or “Vaxart”) today announced that on March 24, 2025, the independent members of the Board of Directors granted inducement equity awards to (i) seven …

WALKER RIVER ANNOUNCES INTERCEPTS INCLUDING 2.62 G/T OVER 41.1 METERS AT THE LAPON GOLD PROJECT
Vancouver, B.C., March 27, 2025 (GLOBE NEWSWIRE) -- Walker River Resources Corp. (“Walker” or the “Company”) (TSX-V: WRR) is pleased to announce additional assay results from the 2024 reverse circulation (“RC”) drill program at the Lapon Canyon portion of …

Septerna Provides Corporate Overview and Reports Fourth Quarter and Full Year 2024 Financial Results
Preclinical Work Advancing with Plans to Select a Next-Generation Oral Small Molecule PTH1R Agonist to Accelerate Toward the Clinic Later This Year Phase 1 Trial for SEP-631, MRGPRX2 NAM Program for Mast Cell Diseases, Expected to Initiate in 2025 Well- …

GCL Subsidiary Named Exclusive Regional Distributor for ‘Elden Ring Nightreign’
SINGAPORE, March 27, 2025 (GLOBE NEWSWIRE) -- GCL Global Holdings Ltd (NASDAQ: GCL) (“GCL” or the “Company”), a leading provider of games and entertainment, today announced that its subsidiary, Epicsoft Asia Pte Ltd (“Epicsoft Asia”), has been appointed by …

CNC Machine Market is expected to expand at a CAGR of 5.5%, potentially surpassing $123 billion by 2034 | Exactitude Consultancy
Luton, Bedfordshire, United Kingdom, March 27, 2025 (GLOBE NEWSWIRE) -- The global CNC (Computer Numerical Control) machine market is on a strong upward trajectory, projected to reach a market value of $77 billion in 2024. Fueled by advancements in …

Bioplastics And Biopolymers Market Key Drivers, Opportunities and Trends | Exactitude Consultancy
Luton, Bedfordshire, United Kingdom, March 27, 2025 (GLOBE NEWSWIRE) -- The global bioplastics and biopolymers market is poised for remarkable growth, projected to reach approximately $21 billion in 2024. With sustainability taking center stage across …

Modular Data Center Market on Track for $89.38 Billion Growth by 2031, Led by Schneider Electric, PCX Holding, Huawei Digital Power Technologies and Delta Electronics – The Insight Partners
US …

PDS Biotech Reports Full Year 2024 Financial Results and Provides Clinical Programs Update
Initiated VERSATILE-003 Phase 3 Clinical Trial Evaluating Versamune® HPV in HPV16-Positive Head and Neck Cancer Conference call and webcast today at 8:00 a.m. Eastern Time PRINCETON, N.J., March 27, 2025 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation ( …

Spectral Medical Announces Fourth Quarter and Fiscal 2024 Results and Provides Corporate Update
TORONTO, March 27, 2025 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic shock, today announced its financial results for the fourth …

Alterity Therapeutics Completes Last Patient Visit in ATH434-202 Open-Label Phase 2 Trial in Multiple System Atrophy
– ATH434 is a Disease Modifying Drug Candidate Targeting Parkinsonian Disorders – – Topline Data Expected Mid-Year 2025 – MELBOURNE, Australia and SAN FRANCISCO, March 27, 2025 (GLOBE NEWSWIRE) -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” …